Nchi: Uingereza
Lugha: Kiingereza
Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)
Trimethoprim
Teva UK Ltd
J01EA01
Trimethoprim
200mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010800; GTIN: 5017007212140
PHARMA CODE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. 1. What Trimethoprim Tablets are and what they are used for 2. What you need to know before you take Trimethoprim Tablets 3. How to take Trimethoprim Tablets 4. Possible side effects 5. How to store Trimethoprim Tablets 6. Contents of the pack and other information WHAT TRIMETHOPRIM TABLETS ARE AND WHAT THEY ARE USED FOR • Trimethoprim Tablets contain the active substance trimethoprim. Trimethoprim belongs to a group of medicines called antibacterials. • Trimethoprim is used for the prevention and treatment of infections, particularly in the urinary and respiratory tracts. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRIMETHOPRIM TABLETS DO NOT TAKE TRIMETHOPRIM TABLETS IF YOU: • are allergic to trimethoprim or any of the other ingredients of this medicine (listed in section 6) • are pregnant or breast-feeding • suffer from any blood disorders such as anaemia • suffer from severe liver problems Trimethoprim should not be administered to premature babies or infants under 4 months of age. The tablet form is not recommended for use in children under 6 years. Alternative dosage forms are available. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Trimethoprim Tablets if you: • have kidney problems/kidney disease or are having dialysis treatment • have folate-deficiency anaemia (a decrease in red blood cells due to a poor diet, which can cause tiredness, headache, a sore mouth and tongue and pale skin) • are at greater risk of hig Soma hati kamili
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Trimethoprim Tablets 200 mg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 200 mg of trimethoprim. Excipients with known effect Each tablet contains 50 mg lactose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet White, normal biconvex tablets, engraved Berk 3H7 or 3H7 with a breakline on reverse. The breakline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Trimethoprim is indicated for the treatment of susceptible infections caused by trimethoprim - sensitive organisms including urinary tract and respiratory tract infections. Trimethoprim is also indicated for the prevention of recurrent urinary tract infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ _ _Acute infections: _ _ _ _Adults and children over 12 years of age: _200 mg twice daily_ _ _ _ _Children 6 years to 12 years: _100 mg twice daily Children under 6 years of age: This dosage form is not suitable for use in children younger than 6 years; a more suitable dosage form (such as a suspension) should be used in this age group._ _ _Elderly:_ Depending on kidney function, see special dosage schedule. Treatment should continue for a period of between 3 days (e.g. uncomplicated bacterial cystitis in women) to 2 weeks depending on the nature and severity of the infection. The first dose can be doubled. _Long-term treatment and prophylactic therapy: _ _ _ _Adults and children over 12 years: _100 mg at night Children 6 years to 12 years of age: 50 mg at night. Where a single dose is required, dosage at bedtime may maximise urinary concentrations. The approximate dosage in children is 2mg trimethoprim per kg body weight per day. This dosage form is not suitable for use in children younger than 12 years; a more suitable dosage form (such as a suspension) should be used in this age group. _ _ _Elderly: _Depending on kidney function, see special do Soma hati kamili